These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

431 related articles for article (PubMed ID: 27506744)

  • 21. MicroRNAs in Neurodegenerative Diseases.
    Quinlan S; Kenny A; Medina M; Engel T; Jimenez-Mateos EM
    Int Rev Cell Mol Biol; 2017; 334():309-343. PubMed ID: 28838542
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Metabolic dysfunction in Alzheimer's disease and related neurodegenerative disorders.
    Cai H; Cong WN; Ji S; Rothman S; Maudsley S; Martin B
    Curr Alzheimer Res; 2012 Jan; 9(1):5-17. PubMed ID: 22329649
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The endocannabinoid pathway in Huntington's disease: a comparison with other neurodegenerative diseases.
    Maccarrone M; Battista N; Centonze D
    Prog Neurobiol; 2007 Apr; 81(5-6):349-79. PubMed ID: 17276576
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Role of miR-137 in Neurodegenerative Disorders.
    Bodai L; Borosta R; Ferencz Á; Kovács M; Zsindely N
    Int J Mol Sci; 2024 Jun; 25(13):. PubMed ID: 39000336
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The cytoskeleton as a novel therapeutic target for old neurodegenerative disorders.
    Eira J; Silva CS; Sousa MM; Liz MA
    Prog Neurobiol; 2016 Jun; 141():61-82. PubMed ID: 27095262
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mitochondrial importance in Alzheimer's, Huntington's and Parkinson's diseases.
    Correia SC; Santos RX; Perry G; Zhu X; Moreira PI; Smith MA
    Adv Exp Med Biol; 2012; 724():205-21. PubMed ID: 22411245
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Autophagy in Neurodegenerative Diseases and Metal Neurotoxicity.
    Zhang Z; Miah M; Culbreth M; Aschner M
    Neurochem Res; 2016 Feb; 41(1-2):409-22. PubMed ID: 26869037
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MicroRNA: Basic concepts and implications for regeneration and repair of neurodegenerative diseases.
    Saraiva C; Esteves M; Bernardino L
    Biochem Pharmacol; 2017 Oct; 141():118-131. PubMed ID: 28709951
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Targeting protein aggregation in neurodegeneration--lessons from polyglutamine disorders.
    Weydt P; La Spada AR
    Expert Opin Ther Targets; 2006 Aug; 10(4):505-13. PubMed ID: 16848688
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Iron misregulation in the brain: a primary cause of neurodegenerative disorders.
    Ke Y; Ming Qian Z
    Lancet Neurol; 2003 Apr; 2(4):246-53. PubMed ID: 12849213
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bioenergetics failure in neurodegenerative diseases: back to the future.
    Saxena U
    Expert Opin Ther Targets; 2012 Apr; 16(4):351-4. PubMed ID: 22339293
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reactive oxygen species: stuck in the middle of neurodegeneration.
    Patten DA; Germain M; Kelly MA; Slack RS
    J Alzheimers Dis; 2010; 20 Suppl 2():S357-67. PubMed ID: 20421690
    [TBL] [Abstract][Full Text] [Related]  

  • 33. NADPH oxidase in brain injury and neurodegenerative disorders.
    Ma MW; Wang J; Zhang Q; Wang R; Dhandapani KM; Vadlamudi RK; Brann DW
    Mol Neurodegener; 2017 Jan; 12(1):7. PubMed ID: 28095923
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mitochondrial quality control in neurodegenerative diseases.
    Dupuis L
    Biochimie; 2014 May; 100():177-83. PubMed ID: 23958438
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mechanisms of Disease: astrocytes in neurodegenerative disease.
    Maragakis NJ; Rothstein JD
    Nat Clin Pract Neurol; 2006 Dec; 2(12):679-89. PubMed ID: 17117171
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Critical role of transglutaminase and other stress proteins during neurodegenerative processes.
    Caccamo D; Currò M; Condello S; Ferlazzo N; Ientile R
    Amino Acids; 2010 Feb; 38(2):653-8. PubMed ID: 19960212
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neuroprotective effects of leptin in the context of obesity and metabolic disorders.
    Davis C; Mudd J; Hawkins M
    Neurobiol Dis; 2014 Dec; 72 Pt A():61-71. PubMed ID: 24780498
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of 5-hydroxymethylcytosine in neurodegeneration.
    Sherwani SI; Khan HA
    Gene; 2015 Oct; 570(1):17-24. PubMed ID: 26115768
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nitric oxide and cellular stress response in brain aging and neurodegenerative disorders: the role of vitagenes.
    Calabrese V; Boyd-Kimball D; Scapagnini G; Butterfield DA
    In Vivo; 2004; 18(3):245-67. PubMed ID: 15341181
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genes and the environment in neurodegeneration.
    Coppedè F; Mancuso M; Siciliano G; Migliore L; Murri L
    Biosci Rep; 2006 Oct; 26(5):341-67. PubMed ID: 17029001
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.